GENEVA, June 2 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (No.7 Kunlunshan Road, Economic And Technological Development ZoneLianyungang, Jiangsu 222047), 江苏恒瑞医药股份有限公司 (中国江苏省连云港市经济技术开发区昆仑山路7号) filed a patent application (PCT/CN2024/133856) for "METHOD FOR TREATING TUMORS WITH ANTI-HER3 ANTIBODY DRUG CONJUGATE AND ANTI-VEGF ANTIBODY" on Nov 22, 2024. With publication no. WO/2025/108438, the details related to the patent application was published on May 30, 2025.
Notably, the patent application was submitted under...